ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer

Prajish Lyer, Shailesh V Shrikhande, Malika Ranjan, Asim Joshi, Nilesh Gardi, Ratnam Prasad, Bhasker Dharavath, Rahul Thorat, Sameer Salunkhe, Bikram Sahoo, Pratik Chandrani, Hitesh Kore, Bhabani Mohanty, Vikram Chaudhari, Anuradha Choughule, Dhananjay Kawle, Pradip Chaudhari, Arvind Ingle, Shripad D Banavali, Poonam GeraMukta R Ramadwar, Kumar P Prabhash, Savio George Barreto, Shilpee Dutt, Amit Dutt

Research output: Contribution to journalArticlepeer-review

33 Citations (Scopus)

Fingerprint

Dive into the research topics of 'ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology